AzTrials
AzTrials

Traumatic Brain InjuriesNCT07890259

Doppler Ultrasonography Parameters and Mortality in Traumatic Brain Injury

An observational study of Traumatic Brain Injuries and Brain Injuries,Traumatic, run by Inonu University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to find out whether blood flow measurements of the brain and neck arteries, obtained with bedside Doppler ultrasonography are associated with neurological outcome and survival in adult patients with traumatic brain injury treated in the intensive care unit. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Transcranial and Carotid Doppler Ultrasonography
How many people
110 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Oct 2026to 1 Jan 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients admitted to the Anesthesiology and Reanimation Intensive Care Unit of Inonu University Turgut Ozal Medical Center with traumatic brain injury.

Who may be able to join

  • Age 18 years or older
  • Admission to the intensive care unit with a diagnosis of traumatic brain injury
  • Informed consent obtained from the patient or a legally authorized representa

Who cannot join

  • Inadequate acoustic temporal window preventing transcranial Doppler measurement
  • Known pre-existing significant carotid or intracranial arterial stenosis or occlusion
  • Pregnancy
  • Death or ICU discharge before the first Doppler measurement could be obtained
  • Refusal of consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Göksel Aydoğan, MD contact

+905342428048

drgoksel5533@gmail.com

Turkey (Türkiye)1 site
  • Inonu University Turgut Ozal Medical Center

    Malatya, Bursa, 44280

    Göksel Aydoğan, MD, 05342428048 ext. +905342428048, drgoksel5533@gmail.com

    Ayşe Belin Özer, MD, Prof., +905334478924, belin.ozer@inonu.edu.tr

Other trials in Turkey (Türkiye)

About this study

Official title: Prognostic Value of Serial Transcranial and Carotid Doppler Ultrasonography Parameters for 30-Day Mortality in Patients With Traumatic Brain Injury in the Intensive Care Unit: A Prospective Observational Study

The purpose of this study is to find out whether blood flow measurements of the brain and neck arteries, obtained with bedside Doppler ultrasonography are associated with neurological outcome and survival in adult patients with traumatic brain injury treated in the intensive care unit. Transcranial and carotid Doppler examinations are performed at three time points during the intensive care stay. Regional cerebral oxygen saturation is also monitored with near-infrared spectroscopy when the device is available. The study does not change patient treatment; all measurements are non-invasive and are performed alongside routine care.

Read the detailed description

Traumatic brain injury (TBI) is a leading cause of death and disability and early identification of patients at high risk of poor outcome remains challenging. Transcranial Doppler (TCD) and carotid Doppler ultrasonography are non-invasive bedside tools that reflect cerebral hemodynamics and may provide prognostic information.

This prospective observational cohort study is conducted in the Anesthesiology and Reanimation Intensive Care Unit of Inonu University Turgut Ozal Medical Center, Malatya, Türkiye. Adult patients admitted with TBI are enrolled after informed consent is obtained from a legally authorized representative.

Doppler measurements are obtained at three time points: within the first 24 hours after ICU admission (T1), at 72 hours (T2), and on day 7 when clinically feasible (T3). Measurements are taken from the common carotid, internal carotid, external carotid, and middle cerebral arteries. Recorded parameters include peak systolic velocity, end-diastolic velocity, time-averaged mean velocity, pulsatility index, and resistive index. Regional cerebral oxygen saturation (rSO2) is monitored with near-infrared spectroscopy when the device is available; if it cannot be obtained, the study will be completed using Doppler and clinical parameters.

The primary outcome is the association between middle cerebral artery pulsatility index and neurological outcome assessed by the Glasgow Outcome Scale / Glasgow Outcome Scale-Extended at 30 days. Secondary outcomes include the association of carotid artery Doppler indices with 30-day mortality, their correlation with Glasgow Coma Scale score, intensive care unit length of stay, and duration of mechanical ventilation, and the predictive performance of Doppler parameters for poor neurological outcome. The planned sample size is approximately 110 patients.

Being tested
Transcranial and Carotid Doppler Ultrasonography
Keywords
Transcranial Doppler Ultrasonography, Carotid Doppler, Pulsatility Index, Resistive Index, Cerebral Hemodynamics, Near-Infrared Spectroscopy, Intensive Care Unit
Medical subject headings
Brain Injuries, Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transcranial and Carotid Doppler UltrasonographyDiagnostic test

    Non-invasive bedside Doppler measurement of peak systolic velocity, end-diastolic velocity, time-averaged mean velocity, pulsatility index, and resistive index in the common carotid, internal carotid, external carotid, and middle cerebral arteries.

Study groups in NCT07890259
Study groupRoleWhat they receive
Patients With Traumatic Brain InjuryAdult patients with traumatic brain injury admitted to the intensive care unit who undergo serial transcranial and carotid Doppler ultrasonography within the first 24 hours after admission, at 72 hours, and on day 7 when clinically feasible.
Receives: Diagnostic Test: Transcranial and Carotid Doppler Ultrasonography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Association Between Middle Cerebral Artery Pulsatility Index and Neurological Outcome

    Middle cerebral artery pulsatility index measured by transcranial Doppler within the first 24 hours after ICU admission, at 72 hours, and on day 7 when clinically feasible will be analyzed for its association with neurological outcome assessed by the Glasgow Outcome Scale / Glasgow Outcome Scale-Extended (GOS/GOSE).

    Measured: 30 days after ICU admission

Secondary outcomes (2)
  1. Association Between Carotid Artery Doppler Indices and Mortality

    Pulsatility index and resistive index of the common carotid, internal carotid, and external carotid arteries will be analyzed for their association with all-cause mortality.

    Measured: 30 days after ICU admission

  2. Correlation Between Doppler Indices and Glasgow Coma Scale Score

    Pulsatility index and resistive index values will be correlated with the Glasgow Coma Scale score recorded at each Doppler measurement time point.

    Measured: Within 24 hours, at 72 hours, and on day 7 after ICU admission

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2026
  2. Study start15 Oct 2026 (estimated)
  3. Primary completion31 Dec 2027 (estimated)
  4. Study completion1 Jan 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
110 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07890259
Sponsor's protocol ID
10811
Status last verified
Oct 2026
First submitted
16 Oct 2026
Last updated
22 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared due to patient confidentiality and the absence of consent for data sharing beyond the study team. Aggregate results will be published in a peer-reviewed journal.

Questions about this trial

What is this clinical trial studying?

An observational study of Traumatic Brain Injuries and Brain Injuries,Traumatic, run by Inonu University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 22 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Göksel Aydoğan, MD (+905342428048, drgoksel5533@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Association Between Middle Cerebral Artery Pulsatility Index and Neurological Outcome (time frame: 30 days after ICU admission). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in